Pharmaceuticals

Leukapheresis Market Performance and Future Outlook at 7.8% CAGR Through 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the leukapheresis market from 2025–2034 with trusted insights from The Business Research Company

What Is The Predicted Size Of The Leukapheresis Industry By 2029?

The leukapheresis market size has shown strong expansion in recent years. It is anticipated to increase from $66.8 billion in 2024 to $72.02 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.8%. The historical growth of this market can be attributed to several factors, including the rising incidence of leukemia and autoimmune diseases, an escalating demand for personalized medicine, progress in stem cell research, improvements in apheresis technologies, an increase in clinical trial activities, and enhanced awareness regarding immunotherapy applications.

The leukapheresis market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $97.11 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.8%. This growth during the forecast period is propelled by factors such as the increasing demand for personalized cell therapies, a surge in clinical trials within immuno-oncology, wider acceptance in regenerative medicine, the expansion of biopharmaceutical manufacturing, more favorable reimbursement policies, and a heightened understanding of cell-based research and therapeutic choices. Significant trends for the upcoming period encompass enhancements in cell separation technologies, the incorporation of AI for optimizing procedures, the creation of portable leukapheresis devices, progress in cell and gene therapy, refined donor screening techniques, and the implementation of cloud-based systems for data tracking.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24277&type=smp

What Major Drivers Are Impacting The Leukapheresis Market?

The increasing incidence of autoimmune conditions is anticipated to fuel the expansion of the leukapheresis market in the future. These are disorders characterized by the immune system erroneously attacking the body’s healthy tissues. A disrupted immune balance, caused by diminished early-life microbial exposure and contemporary environmental elements, contributes to a rise in autoimmune disorders. Leukapheresis serves as a treatment for autoimmune diseases by specifically eliminating detrimental white blood cells involved in the immune system’s assault on the body’s own tissues. An example highlighting this trend is data from November 2024, provided by Versorgungsatlas.de, a Germany-based organization, indicating that in 2022, out of 73,241,305 insured individuals, 6,304,340 received a diagnosis of at least one autoimmune disease, leading to a raw prevalence rate of 8.61%. Consequently, the growing prevalence of autoimmune diseases is stimulating the expansion of the leukapheresis market.

Which Segment Categories Are Driving Maximum Growth In The Leukapheresis Market?

The leukapheresis market covered in this report is segmented –

1) By Type: Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis

2) By Product: Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables

3) By Application: Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications

4) By End User: Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers

Subsegments:

1) By Granulocyte Apheresis: Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis

2) By Lymphocyte Apheresis: T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis

3) By Monocyte Apheresis: Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes

Which Long-Term Trends Will Play A Crucial Role In The Leukapheresis Market?

Major companies active in the leukapheresis market are concentrating on advancements like creating GMP-grade leukopaks to boost the quality and efficiency of cell therapy manufacturing. GMP-grade leukopaks are products derived from leukapheresis, processed under rigorous good manufacturing practice (GMP) standards, which ensures the high viability and functionality of collected cells for therapeutic applications. For example, in November 2024, Sanguine Biosciences, a US-based biotechnology company, introduced LeukoCer, a GMP-grade leukopak developed to streamline workflows and accelerate cell therapy development. LeukoCert supplies high-quality starting materials, available in fresh whole or half packs, produced in line with strict GMP standards, thereby empowering researchers to advance their studies and bring new cell therapies to market faster.

Who Are The Dominant Players In The Leukapheresis Market Today?

Major companies operating in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., STEMCELL Technologies Inc., Haemonetics Corporation, Macopharma, Discovery Life Sciences, BioIVT LLC, StemExpress LLC, MEDICA S.p.A, AllCells LLC, Caltag Medsystems Ltd., Miltenyi Biotec, Immune Therapy Holdings AB, Cellsep Laboratories, Accegen Biotec, Key Biologics LLC, HemaCare Corporation, Puriblood Medical, Cytopheron Technologies, Adacyte Therapeutics.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/leukapheresis-global-market-report

Which Region Is At The Forefront Of Innovation In The Leukapheresis Market?

North America was the largest region in the leukapheresis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukapheresis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24277&type=smp

Browse Through More Reports Similar to the Global Leukapheresis Market 2025, By The Business Research Company

Blood Collection Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-collection-devices-global-market-report

Blood And Blood Components Market 2025

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-market

Self Monitoring Blood Glucose Smbg Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/self-monitoring-blood-glucose-smbg-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795